AstraZeneca Plc was raided by European Union antitrust officials as part of a probe into whether drugmakers colluded to keep cheaper copies of medicines off the market.
The European Commission said it raided the premises of “a limited number of” pharmaceutical companies that may have slowed the sale of generic medicines. AstraZeneca said inspections at its premises concerned the ulcer drug Nexium.
“The commission has reason to believe that the companies concerned may have acted individually or jointly, notably to delay generic entry for a particular medicine,” the EU executive, which declined to name the companies, said in an e- mailed statement. “This could be a potential violation of EU antitrust rules.”
via bloomberg.com
No comments:
Post a Comment